3) 清野裕. 糖尿病の新しい概念. 最新医学. 50, 1995, 639-45.
4) United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes (UKPDS33). Lancet. 352 (9131), 1998, 837-53.
5) Holman, RR. et al. 10-year follow-up of intensive glucose control in type2 diabetes. N. Engl. J. Med. 359 (15), 2008, 1577-89.
9) Christianne, L. et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA. 311 (22), 2014, 2288-96.